Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Harvard Bioscience (NQ: HBIO ) 2.880 -0.050 (-1.71%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Harvard Bioscience < Previous 1 2 3 Next > Harvard Bioscience Schedules Second Quarter 2023 Earnings Conference Call for August 8, 2023 at 8:00 AM ET July 27, 2023 From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience Set to Join Russell 2000® and 3000® Indexes June 22, 2023 From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer June 20, 2023 Has served in interim role since January 2023 From Harvard Bioscience, Inc. Via GlobeNewswire Why Harvard Bioscience Stock Rose This Week April 27, 2023 The company reported improved revenue in Q1. Via The Motley Fool Harvard Bioscience's Return On Capital Employed Overview March 14, 2023 Via Benzinga Earnings Preview: Harvard Bioscience March 08, 2023 Via Benzinga Harvard Bioscience to Present at Sidoti Micro Cap Virtual Conference May 10th, 2023 May 02, 2023 From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience Announces First Quarter 2023 Financial Results April 25, 2023 From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience Announces Initial Order for Integrated Animal Behavior Monitoring System April 18, 2023 Designed to meet the pre-clinical testing needs of CROs, pharma and research laboratories From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience Schedules First Quarter 2023 Earnings Conference Call for April 25, 2023 at 9:00 AM ET April 17, 2023 From Harvard Bioscience, Inc. Via GlobeNewswire Top 5 Health Care Stocks That May Fall Off A Cliff This Quarter April 17, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023 March 16, 2023 From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023 March 16, 2023 From Harvard Bioscience, Inc. Via GlobeNewswire Over $7M Bet On This Consumer Defensive Stock? Check Out These 4 Penny Stocks Insiders Are Buying March 16, 2023 The Dow Jones closed lower by more than 250 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Harvard Bioscience Announces Fourth Quarter 2022 Financial Results March 09, 2023 From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience Schedules Fourth Quarter 2022 Earnings Conference Call for March 9, 2023 at 8:00 AM ET February 28, 2023 From Harvard Bioscience, Inc. Via GlobeNewswire 10 Stocks Under $10 for 2023 January 03, 2023 In 2023, the only certainty will be uncertainty. Investors should keep their portfolios flexible with these stocks under $10. Via InvestorPlace Harvard Bioscience Announces CFO Transition December 12, 2022 From Harvard Bioscience, Inc. Via GlobeNewswire Harvard Bioscience Announces Third Quarter 2022 Financial Results November 08, 2022 “Fighting through challenging times while building the company and new technologies for the future.” From Harvard Bioscience, Inc. Via GlobeNewswire Earnings Preview: Harvard Bioscience November 07, 2022 Harvard Bioscience (NASDAQ:HBIO) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Harvard... Via Benzinga Harvard Bioscience Schedules Third Quarter 2022 Earnings Conference Call for November 8, 2022 at 4:30 PM ET November 02, 2022 From Harvard Bioscience, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session August 22, 2022 Gainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.8% to $0.97 during Monday's after-market session. The company's market cap stands at $31.6 million. Via Benzinga $92 Million Bet On This Penny Stock? Also Check Out Other 3 Stocks Under $5 Insiders Are Buying August 19, 2022 U.S. initial jobless claims dropped by 2,000 to 250,000 the week ended August 13th. Investors, meanwhile, focused on some notable insider trades. Via Benzinga Stocks That Hit 52-Week Lows On Friday August 12, 2022 On Friday, 39 companies reached new 52-week lows. Via Benzinga Harvard Bioscience Schedules Second Quarter 2022 Earnings Conference Call for August 4, 2022 at 8:00 AM ET July 26, 2022 From Harvard Bioscience, Inc. Via GlobeNewswire Looking Into Harvard Bioscience's Return On Capital Employed May 19, 2022 Harvard Bioscience (NASDAQ:HBIO) brought in sales totaling $28.78 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 815.92%, resulting in a loss of $6.88... Via Benzinga Recap: Harvard Bioscience Q1 Earnings May 04, 2022 Harvard Bioscience (NASDAQ:HBIO) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout March 08, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative... Via Benzinga 81 Biggest Movers From Yesterday May 05, 2022 Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday. Via Benzinga 50 Stocks Moving In Wednesday's Mid-Day Session May 04, 2022 Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on Tuesday. Sharps Technology, Inc. (NASDAQ: STSS) rose 31.4% to $1.6815 after... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.